© 2002 European Molecular Biology OrganizationEMBO reports vol. 3 | no. 1 | pp 95–100 | 2002 95
Dynamic association of human insulin receptor
with lipid rafts in cells lacking caveolae
Saara Vainio, Sanna Heino, Jan-Eric Månsson1, Pam Fredman1, Esa Kuismanen2,
Outi Vaarala & Elina Ikonen+
Department of Molecular Medicine, National Public Health Institute, Biomedicum Helsinki, PO Box 104, Haartmaninkatu 8, 00251 Helsinki,2Department of
Biosciences, Division of Biochemistry, Viikki Biocenter, University of Helsinki, PO Box 56, 00014 Helsinki, Finland and1Institute of Clinical Neuroscience,
Göteborg University, Sahlgrenska University Hospital/Mölndal, SE 43180 Molndal, Sweden
Received July 4, 2001; revised November 5, 2001; accepted November 16, 2001
Cholesterol-sphingolipid rich plasma membrane domains,
known as rafts, have emerged as important regulators of signal
transduction. The adipocyte insulin receptor (IR) is localized to
and signals via caveolae that are formed by polymerization of
caveolins. Caveolin binds to IR and stimulates signalling. We
report that, in liver-derived cells lacking caveolae, auto-
phosphorylation of the endogenous IR is dependent on raft
lipids, being compromised by acute cyclodextrin-mediated
cholesterol depletion or by antibody clustering of glycosphingo-
lipids. Moreover, we provide evidence that IR becomes
recruited to detergent-resistant domains upon ligand binding
and that clustering of GM2 ganglioside inhibits IR signalling
apparently by excluding the ligand-bound IR from these
domains. Our results indicate that, in cells derived from liver,
an important insulin target tissue, caveolae are not required
for insulin signalling. Rather, the dynamic recruitment of the
ligand-bound IR into rafts may serve to regulate interactions in
the initiation of the IR signalling cascade.
Insulin is an anabolic hormone with a central role in carbo-
hydrate and lipid metabolism and in cell growth. Insulin exerts
its effects via insulin receptor (IR), a transmembrane receptor tyro-
sine kinase forming a stable heterotetramer of two α-subunits
and two β-subunits (White and Kahn, 1994). The extracellular
α-subunits contain the insulin-binding sites, whereas the β-subunits
form the transmembrane and intracellular parts of the receptor,
including the kinase domain. Upon insulin binding, IR under-
goes a conformational change that allows trans-phosphorylation
of the catalytic sites on multiple tyrosine residues (Hubbard
et al., 1994). IR autophosphorylation is needed for receptor
activation. A number of docking proteins, including the insulin
receptor substrates (IRSs), are then tyrosine-phosphorylated by
the active IR, and this creates recognition sites for binding to the
SH2 domains in various signalling proteins (Saltiel, 2001).
The most important tissues for insulin action are liver, adipose
tissue and striated muscle. The concentration of IR is high in
these tissues, with more than 200 000 receptors on adipocytes
and hepatocytes (White and Kahn, 1994). In adipocytes, IRs are
sequestered in caveolar invaginations of the plasma membrane
and are dependent on caveolae for signalling (Gustavsson et al.,
1999). IR has a consensus binding site for interaction with
caveolin (Couet et al., 1997), the cholesterol-binding structural
protein of caveolae, and interaction of IR with caveolin leads to
an increase in IR kinase activity (Yamamoto et al., 1998;
Nystrom et al., 1999). Whereas caveolae are present at high
concentrations on adipocytes and muscle cells, there are rela-
tively few caveolae in hepatocytes (Fielding and Fielding, 2000;
Calvo et al., 2001). Moreover, in hepatocytes, the binding of
insulin to its receptor occurs preferentially on microvilli,
followed by redistribution of the receptor–ligand complex to
non-villous segments of the membrane from where it is internal-
ized via coated pits (Carpentier et al., 1985, 1992).
Increasing evidence suggests that cholesterol-sphingolipid
rich membrane microdomains, known as lipid rafts, play an
important role in signal transduction by functioning as platforms
for signalling receptors (Simons and Toomre, 2000). Because of
their presumably small size (beyond the resolution of light
microscopy), individual rafts are likely to host only a subset of
raft proteins. However, rafts may become clustered and this
further enhances protein interactions, thus triggering or amplifying
signalling (Janes et al., 1999).
+Corresponding author. Tel: +358 9 4744 8469; Fax: +358 9 4744 8960; E-mail: email@example.com
96 EMBO reports vol. 3 | no. 1 | 2002
S. Vainio et al.
Caveolae represent a subset of rafts (Simons and Toomre,
2000). However, the regulation of specific signalling events by
caveolar lipids is difficult to dissect from the dependence of
caveolar integrity on caveolin–cholesterol oligomers. In this
work, we have analysed the role of the lipid microenvironment
in the initiation of the insulin signalling cascade in a hepatic cell
line that expresses IRs but lacks caveolae. We demonstrate that
acute changes in cholesterol concentration or local sphingolipid
distribution affect insulin signalling and provide evidence for the
dynamic recruitment of IR into rafts upon activation.
The human hepatoma HuH7 cells express very low levels of
caveolin-1 and caveolin-2 in comparison with differentiated
3T3-L1 adipocytes as judged by western blotting (Figure 1A).
Moreover, no morphologically identifiable caveolae were found
in the HuH7 cell plasma membrane by electron microscopy
(Figure 1B). HuH7 cells express biochemically detectable levels
of endogenous IR and respond metabolically to insulin, e.g. by
increasing lipogenesis (data not shown). Thus, these cells offer a
model system for dissecting the role of non-caveolar raft
domains in insulin signalling.
Cholesterol depletion inhibits IR
and IRS-1 phosphorylation
Cholesterol depletion has been shown to inhibit raft-dependent
signalling (Simons and Toomre, 2000). Therefore, we extracted
cholesterol from HuH7 cells by acute treatment with cyclo-
dextrin and analysed its effect on IR signalling. HuH7 cells were
incubated in the presence of 10 mM methyl-β-cyclodextrin for
15 min at 37°C. This resulted in ∼50% depletion of cellular
cholesterol as judged by the efflux of [14C]cholesterol from
labelled cells (data not shown). During the last 10 min of incub-
ation, the cells were stimulated with insulin. Immunoblotting of
the cell lysates with anti-phosphotyrosine (anti-PY) and anti-IRβ
antibodies revealed that the cholesterol extraction resulted in an
∼60% decrease in IR phosphorylation in insulin-stimulated cells
(Figure 2). The insulin-dependent tyrosine phosphorylation of
IRS-1 was also impaired by ∼50%, whereas IRS-2 phosphoryl-
ation was not detectable (Figure 2).
inhibits IR phosphorylation
Clustering of raft components has been shown to modulate raft-
dependent signalling events. For example, Src-kinase phosphoryl-
ation on the cytosolic side of the membrane is stimulated by
patching of glycosphingolipids or glycosyl phosphatidylinositol
(GPI) anchored proteins on the other side (Horejsi et al., 1998;
Kasahara and Sanai, 1999). We next investigated the effect of
Fig. 1. Caveolin expression in HuH7 cells and 3T3-L1 adipocytes. (A) Cell
lysate (20 µg) was immunoblotted with anti-caveolin-1 and anti-caveolin-2
and 3T3-L1 adipocyte plasma membrane. Caveolae are abundant in 3T3-L1
adipocytes (arrows) but absent in HuH7 cells.
Fig. 2. Effect of cholesterol depletion on IR and IRS-1 phosphorylation.
(A) HuH7 cells were incubated in the presence (+) or absence (-) of methyl-
β-cyclodextrin (CD) for 5 min. Insulin (ins) was then added to the indicated
samples and incubation continued for 10 min. Protein (20 µg) from cell
lysates was analysed by western blotting using anti-PY antibody (in
duplicate). The locations of IRS-1, IRS-2 and IR are indicated and their levels
in the same samples shown by western blotting. Incubation with CD alone
also affected protein phosphorylation, as indicated by the appearance of an
unknown ∼160 kDa band in the +CD samples. (B) Quantitation of anti-PY
blotting data from three independent experiments. Error bars = SEM (n = 4–6);
*P < 0.05.
EMBO reports vol. 3 | no. 1 | 2002 97
Insulin signalling without caveolae
anti-glycosphingolipid antibody cross-linking on insulin signal-
ling. An anti-ganglioside GM2 IgM antibody was chosen
because HuH7 cells were found to contain high levels of GM2
(0.8 nmol/mg protein). The clustering was performed at 12°C,
according to Harder et al. (1998), by incubating living cells for
1 h in the presence of the primary anti-glycosphingolipid anti-
bodies followed by 1 h in the presence of FITC-conjugated anti-
IgM secondary antibodies. Confocal microscopy revealed that,
after GM2 antibody patching, the staining was distributed in
micron-size clusters (Figure 3A). No clustering of GM2 was
observed when the secondary antibody was incubated after fixa-
tion (Figure 3A). When insulin-dependent tyrosine phosphoryla-
tion of IR was analysed upon anti-GM2 clustering, we found it to
be inhibited by ∼70% compared to incubation with irrelevant
antibodies (Figure 3B and C). To test whether this effect of
glycolipid clustering is restricted to the hepatoma cells, we
carried out the same experiment using primary mouse hepato-
cytes. Both the patching of GM2 and the parallel reduction in IR
phosphorylation were reproduced in these cells (see Supple-
mentary figure 1 available at EMBO reports Online).
Association of IR with
Our observations suggest that an intact raft lipid environment is
important for insulin signalling via IR. To further investigate the
underlying mechanism, we studied the association of IR with
detergent-resistant membranes (DRMs). Triton X-100 insolubility
at 4°C is a commonly used criterion for detecting raft association
of proteins (London and Brown, 2000). To analyse whether IR
associates with DRMs in HuH7 cells, insulin-stimulated and
basal cells were lysed in 0.1% Triton X-100 on ice, and the
lysates were subjected to Optiprep gradient fractionation in the
presence of the detergent. Western blot analysis of the proteins
precipitated from the fractions indicated that the distribution of
IR in the gradient changed in response to insulin (Figure 4A). In
the absence of ligand, the vast majority of the receptors were
found at the bottom of the gradient (i.e. solubilized by the deter-
gent), whereas, in the presence of insulin, a significant fraction
of IR floated to the upper fractions representing DRMs. The non-
raft protein transferrin receptor was completely solubilized by
0.1% Triton X-100 (Figure 4A). Similar results were obtained
when using 1% Triton X-100, although the proportion of IR asso-
ciating with DRMs was slightly smaller (Supplementary figure 2,
and data not shown). These results indicate that, in the
hepatoma cells, IR can partition into detergent-soluble or
detergent-resistant domains, and its association with DRMs
depends on ligand binding. Moreover, we found IR association
Fig. 3. Effect of GM2 clustering on IR phosphorylation. (A) Confocal images
of HuH7 cells stained with anti-GM2 antibodies. Cells were incubated in the
presence of anti-GM2 for 1 h at 12°C, followed by secondary antibody
(patched) or BSA (non-patched) for 1 h at 12°C. After fixing with PFA, non-
patched cells were stained with the secondary antibody. Lower panels show
the areas marked in the upper panels. (B) Cells were patched with anti-GM2
or irrelevant antibodies (anti LDL-receptor antibody or a mixture of mouse
IgM antibodies) for 1 h at 12°C, followed by respective secondary antibodies
(1 h at 12°C), and incubated in the presence or absence of insulin for 3 min at
37°C. Cell lysates (20 µg of protein) were analysed by western blotting using
anti-PY antibody. (C) Quantitation of the western blotting data. Error bars =
SEM (n = 4); *P < 0.05.
Fig. 4. Association of IR with DRMs. (A) Basal and insulin-stimulated
(1.5 min) cells were solubilized in 0.1% Triton X-100 on ice and subjected to
Triton–Optiprep (OP) gradient fractionation. Equal volume from each
fraction was TCA precipitated and the precipitated proteins analysed by
western blotting using anti-IRβ and anti-transferrin receptor (Tfn-R)
antibodies. (B) Cells were cholesterol depleted and insulin stimulated as in
Figure 2. For cholesterol repletion, depleted cells were incubated for 2 h with
CD/cholesterol complex prior to insulin stimulation (10 min). Samples
solubilized in 0.1% Triton X-100 were analysed as in (A), using anti-IRβ
98 EMBO reports vol. 3 | no. 1 | 2002
S. Vainio et al.
with DRMs to be cholesterol dependent, as it was abolished by
the cyclodextrin treatment and recovered after subsequent
cholesterol repletion (Figure 4B).
Effect of glycosphingolipid clustering
on the association of IR with rafts
To test whether glycosphingolipid clustering affects the raft asso-
ciation of IR, we studied the distribution of the receptor in the
Triton–Optiprep gradient after antibody patching and insulin
treatment. Immunoblotting with anti-IRβ antibody revealed that,
in cells patched with irrelevant antibodies, the receptor was effi-
ciently recovered from DRMs, whereas, in anti-GM2-patched
cells, the receptor was excluded from them (Figure 5A). When
analysing the tyrosine phosphorylation of IR, the phosphoryl-
ation level in anti-GM2-patched cells was found to be markedly
lower than in control cells (Figure 5A), in accordance with the
previous experiment (Figure 3).
Our data suggest that IR becomes excluded from rafts once
GM2 is clustered and presumably stabilized in them. To test
whether the segregation of IR and GM2 could be observed
morphologically in intact cells, we added FITC-coupled insulin
onto cells in which GM2 had been clustered with antibodies and
visualized the staining by confocal microscopy. We found that
insulin labelling localized preferentially to clusters in the inter-
vening areas of GM2 patches (Figure 5B). In non-patched cells,
insulin gave a similar punctate staining, whereas the GM2
immunoreactivity seemed essentially uniformly distributed,
partially overlapping with that of insulin (Figure 5B). The results
suggest that GM2 clustering is accompanied by segregation of IR
and the glycolipid and that clustering does not inhibit insulin
binding to its receptor.
Our results indicate that manipulation of raft lipids (i.e. choles-
terol and sphingolipids) modulate IR signalling in the absence of
caveolae. Furthermore, distinct differences are found between
the caveolae-dependent IR signalling described in adipocytes
and the caveolae-independent signalling, analysed here in
hepatoma cells. First, IR appears to be restricted to caveolae in
adipocytes (Gustavsson et al., 1999), whereas its raft affinity
seems to increase upon ligand binding in hepatoma cells. This
may be related to the finding that IRs were found preferentially
as groups in adipocytes and as single receptors in hepatocytes
(Jarett et al., 1980). Secondly, the removal of cholesterol by
cyclodextrin treatment inhibits IRS-1 phosphorylation without
affecting IR autophosphorylation in adipocytes (Parpal et al.,
2001), whereas IR phosphorylation is also inhibited in hepatoma
cells. It is possible that the lack of caveolae makes IR more
vulnerable to the effects of cholesterol extraction. Interestingly,
we have observed that overexpression of caveolin-1 using
recombinant Semliki Forest virus augments IR phosphorylation
in HuH7 cells (unpublished data), in line with the stimulatory
role of caveolin in insulin signalling observed in other cells
(Yamamoto et al., 1998; Nystrom et al., 1999).
Based on the available IR crystal structure, the constitutively
oligomeric receptor occupies a relatively large area in the plane
of the membrane (~80Å in diameter) (Ottensmeyer et al., 2000).
Insulin binding changes receptor conformation to one that is
Fig. 5. The effect of antibody patching on IR raft association. (A) Following antibody patching as in Figure 3B, cells were treated with insulin for 1.5 min,
solubilized and fractionated as in Figure 4. The distribution of IR and tyrosine-phosphorylated IR was analysed by western blotting. (B) Distribution of GM2 and
FITC-insulin in non-patched and anti-GM2-patched cells by confocal microscopy. GM2 staining was performed as in Figure 3, and insulin was added for 5 min
before fixation. Ligand-induced receptor clustering (Jeffrey, 1982) may contribute to the punctate FITC-insulin staining pattern. Insulin preferentially segregates
from clustered GM2 (arrows).
EMBO reports vol. 3 | no. 1 | 2002 99
Insulin signalling without caveolae
permissive for phosphorylation. Although dimerization is not
required for activation, unlike in several other transmembrane
receptor tyrosine kinases, there is considerable evidence for IR
self-aggregation. This has been experimentally observed, e.g. by
IR antibodies (Heffetz and Zick, 1986), and also suggested to be
mediated by the ligand itself (Jeffrey, 1982). According to our
data, the dynamic association of IR with rafts may provide an
additional mode of regulation into this framework. The unoccu-
pied receptor seems to have low affinity for rafts, as assessed by
detergent solubilization, and, upon insulin binding, its raft
affinity increases. It is possible that the nature of the ligand-
bound IR may favour its partitioning into DRMs (independent of
raft association in vivo). However, ligand binding alone is not
sufficient for attaining detergent insolubility, as the ligand-bound
IR can be excluded from DRMs by cholesterol depletion or
Apart from caveolin interaction, the cue conferring IR raft
association could be, for example, fatty acylation as the
membrane spanning β-subunit is palmitoylated (Hedo et al.,
1987; Magee and Siddle, 1988). Raft association may favour the
preservation of the active receptor conformation, and clustering
of individual rafts could account for the observed receptor
aggregation, helping to potentiate signalling by concentrating
downstream components, as has been shown for other signalling
cascades. It is also conceivable that IR is constitutively associ-
ated with rafts but has only moderate affinity for rafts in vivo that
can be disrupted by non-ionic detergents, as suggested for the
T-cell receptor (Janes et al., 1999). In this scenario, IR activation
could involve aggregation and stabilization of rafts already
harbouring the receptor.
Cyclodextrin treatments. To deplete cholesterol, HuH7 cells
(Nakabayashi et al., 1982) were incubated with 10 mM methyl-
β-cyclodextrin for 5 min at 37°C. Insulin (1.0 IU/ml) was added
to the indicated samples, and the incubation continued for
10 min. Cells were then lysed for western blotting or gradient
fractionation. To measure cholesterol efflux, cells were labelled
overnight with 0.05 µCi/ml [14C]cholesterol in growth medium
and incubated in the presence of cyclodextrin as above. Radio-
activity from cells and media was measured by liquid-scintilla-
tion counting. To replete cholesterol, depleted cells were
incubated for 2 h with methyl-β-cyclodextrin/cholesterol
complex (molar ratio 8:1).
Glycosphingolipid clustering. Cells were incubated at 12°C for
1 h in the presence of 20 µg/ml anti-GM2 [mouse IgM against
human GM2 (Karlsson et al., 1990)] or irrelevant antibody (anti-
LDL receptor antibody C7 or mouse IgM MOPC 104C), washed
and incubated for 1 h at 12°C in the presence of secondary anti-
bodies. After insulin stimulation at 37°C, cells were lysed for
western blotting or gradient fractionation. Cells on cover slips
were fixed for 2 h in 4% PFA at room temperature after incub-
ation with the secondary antibodies. To visualize GM2 staining
without patching, staining with the secondary antibody was
done after fixation. To examine the distribution of occupied IR in
patched and non-patched cells, FITC-labelled insulin (30 ng/µl)
was added for 5 min at 12°C before fixation.
Western blotting, flotation gradients. For western blotting, cells
were lysed in buffer containing 1% SDS, 10 mM Tris–HCl,
pH 7.5, phosphatase and protease inhibitors and 20 µg of
protein resolved by SDS–PAGE. For western blotting with anti-
PY antibody, filters were blocked with 3% BSA; otherwise
5% milk was used. The signal visualized by enhanced chemi-
luminiscence detection was quantified by normalizing the
intensity of the anti-PY band with the intensity of the IR band in
the same blot. The association of IR with DRMs was studied by
lysing the cells in 0.1% Triton X-100 on ice and fractionating in
Triton–Optiprep gradients according to Heino et al. (2000).
Proteins TCA precipitated from the fractions were analysed by
Supplementary data. Supplementary data are available at
EMBO reports Online.
We thank Antti Virkamäki for valuable comments. This work
was financially supported by the Sigrid Juselius Foundation,
Jenny and Antti Wihuri Foundation, Swedish Medical Research
council and the Academy of Finland.
Calvo, M., Tebar, F., Lopez-Iglesias, C. and Enrich, C. (2001) Morphologic
and functional characterization of caveolae in rat liver hepatocytes.
Hepatology, 33, 1259–1269.
Carpentier, J.L., Fehlmann, M., Van Obberghen, E., Gorden, P. and Orci, L.
(1985) Redistribution of 125I-insulin on the surface of rat hepatocytes as
a function of dissociation time. Diabetes, 34, 1002–1007.
Carpentier, J.L., Paccaud, J.P., Gorden, P., Rutter, W.J. and Orci, L. (1992)
Insulin-induced surface redistribution regulates internalization of the
insulin receptor and requires its autophosphorylation. Proc. Natl Acad.
Sci. USA, 89, 162–166.
Couet, J., Sargiacomo, M. and Lisanti, M.P. (1997) Interaction of a receptor
tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively
regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem.,
Fielding, C.J. and Fielding, P.E. (2000) Cholesterol and caveolae: structural
and functional relationships. Biochim. Biophys. Acta, 1529, 210–222.
Gustavsson, J. et al. (1999) Localization of the insulin receptor in caveolae of
adipocyte plasma membrane. FASEB J., 13, 1961–1971.
Harder, T., Scheiffele, P., Verkade, P. and Simons, K. (1998) Lipid domain
structure of the plasma membrane revealed by patching of membrane
components. J. Cell Biol., 141, 929–942.
Hedo, J.A., Collier, E. and Watkinson, A. (1987) Myristyl and palmityl
acylation of the insulin receptor. J. Biol. Chem., 262, 954–957.
Heffetz, D. and Zick, Y. (1986) Receptor aggregation is necessary for
Heino, S., Lusa, S., Somerharju, P., Ehnholm, C., Olkkonen, V.M. and
Ikonen, E. (2000) Dissecting the role of the Golgi complex and lipid rafts
in biosynthetic transport of cholesterol to the cell surface. Proc. Natl
Acad. Sci. USA, 97, 8375–8380.
Horejsi, V., Cebecauer, M., Cerny, J., Brdicka, T., Angelisova, P. and
Drbal, K. (1998) Signal transduction in leucocytes via GPI-anchored
proteins: an experimental artefact or an aspect of immunoreceptor
function? Immunol. Lett., 63, 63–73.
Hubbard, S.R., Wei, L., Ellis, L. and Hendrickson, W.A. (1994) Crystal
structure of the tyrosine kinase domain of the human insulin receptor.
Nature, 372, 746–754.
Janes, P.W., Ley, S.C. and Magee, A.I. (1999) Aggregation of lipid rafts
accompanies signalling via the T cell antigen receptor. J. Cell Biol., 147,
100 EMBO reports vol. 3 | no. 1 | 2002
S. Vainio et al.
Jarett, L., Schweitzer, J.B. and Smith, R.M. (1980) Insulin receptors:
differences in structural organization on adipocyte and liver plasma
membranes. Science, 210, 1127–1128.
Jeffrey, P.D. (1982) The interaction of insulin with its receptor: cross-linking
via insulin association as the source of receptor clustering. Diabetologia,
23, 381–385, 391–392.
Karlsson, G., Mansson, J.E., Wikstrand, C., Bigner, D. and Svennerholm, L.
(1990) Characterization of the binding epitope of the monoclonal antibody
DMAb-1to ganglioside GM2. Biochim. Biophys. Acta, 1043, 267–272.
Kasahara, K. and Sanai, Y. (1999) Possible roles of glycosphingolipids in
lipid rafts. Biophys. Chem., 82, 121–127.
London, E. and Brown, D.A. (2000) Insolubility of lipids in Triton X-100:
physical origin and relationship to sphingolipid/cholesterol membrane
domains (rafts). Biochim. Biophys. Acta, 1508, 182–195.
Magee, A.I. and Siddle, K. (1988) Insulin and IGF-1 receptors contain
covalently bound palmitic acid. J. Cell. Biochem., 37, 347–357.
Nakabayashi, H., Taketa, K., Miyano, K., Yamane, T. and Sato, J. (1982)
Growth of human hepatoma cells lines with differentiated functions in
chemically defined medium. Cancer Res., 42, 3858–3863.
Nystrom, F.H., Chen, H., Cong, L.N., Li, Y. and Quon, M.J. (1999) Caveolin-1
interacts with the insulin receptor and can differentially modulate insulin
signalling in transfected Cos-7 cells and rat adipose cells. Mol.
Endocrinol., 13, 2013–2024.
Ottensmeyer, F.P., Beniac, D.R., Luo, R.Z. and Yip, C.C. (2000) Mechanism
of transmembrane signalling: insulin binding and the insulin receptor.
Biochemistry, 39, 12103–12112.
Parpal, S., Karlsson, M., Thorn, H. and Stralfors, P. (2001) Cholesterol
depletion disrupts caveolae and insulin receptor signalling for metabolic
control via insulin receptor substrate-1, but not for mitogen-activated
protein kinase control. J. Biol. Chem., 276, 9670–9678.
Saltiel, A.R. (2001) New perspectives into the molecular pathogenesis and
treatment of type 2 diabetes. Cell, 104, 517–529.
Simons, K. and Toomre, D. (2000) Lipid rafts and signal transduction. Nature
Rev. Mol. Cell Biol., 1, 31–39.
White, M.F. and Kahn, C.R. (1994) The insulin signalling system. J. Biol.
Chem., 269, 1–4.
Yamamoto, M., Toya, Y., Schwencke, C., Lisanti, M.P., Myers, M.G. Jr and
Ishikawa, Y. (1998) Caveolin is anactivator of insulinreceptor signalling.
J. Biol. Chem., 273, 26962–26968.